A Study to Find a Suitable Dose of Exl-111 for Further Research

Clinical trial NCT07356713 · RECRUITING

Trial details

NCT number: NCT07356713
Sponsor: Excellergy Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Disease

Start date: 2026-01-08
Primary completion: 2026-12-07
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.